Resultados de búsqueda - Morris J. Brown
- Mostrando 1 - 20 Resultados de 48
- Ir a la Siguiente Página
-
1
-
2
-
3
Primary aldosteronism: molecular medicine meets public health por Elena Azizan, William Drake, Morris J. Brown
Publicado 2023Revisão -
4
-
5
-
6
-
7
A 5‐hydroxytryptamine receptor in human atrium por Alberto J. Kaumann, Louise Sanders, Anthony Brown, Kenneth Murray, Morris J. Brown
Publicado 1990Artigo -
8
-
9
A Double-Blind, Placebo-Controlled, Crossover Trial Comparing the Effects of Amiloride and Hydrochlorothiazide on Glucose Tolerance in Patients With Essential Hypertension por Anna Stears, Sarah H. Woods, Michaela Watts, Timothy J. Burton, Johann Graggaber, Fraz Mir, Morris J. Brown
Publicado 2012Artigo -
10
-
11
-
12
-
13
Outcomes With Nifedipine GITS or Co-Amilozide in Hypertensive Diabetics and Nondiabetics in Intervention as a Goal in Hypertension (INSIGHT) por Giuseppe Mancia, Morris J. Brown, A Castaigne, Peter de Leeuw, Christopher R. Palmer, Talma Rosenthal, Gilbert Wagener, Luís M. Ruilope
Publicado 2003Artigo -
14
-
15
Microarray, qPCR, and<i>KCNJ5</i>Sequencing of Aldosterone-Producing Adenomas Reveal Differences in Genotype and Phenotype between Zona Glomerulosa- and Zona Fasciculata-Like Tumor... por Elena Azizan, Brian Lam, Stephen Newhouse, Junhua Zhou, Rhoda E. Kuc, Jennifer Clarke, Lisa Happerfield, Alison Marker, Gary J. Hoffman, Morris J. Brown
Publicado 2012Artigo -
16
Evaluation of the Sensitivity and Specificity of<sup>11</sup>C-Metomidate Positron Emission Tomography (PET)-CT for Lateralizing Aldosterone Secretion by Conn's Adenomas por Timothy J. Burton, Isla S. Mackenzie, Kottekkattu Balan, Brendan Koo, Nick Bird, Dmitry Soloviev, Elena Azizan, Franklin I. Aigbirhio, Mark Gurnell, Morris J. Brown
Publicado 2011Artigo -
17
-
18
Aldehyde Dehydrogenase 2 Plays a Role in the Bioactivation of Nitroglycerin in Humans por Isla S. Mackenzie, Kaisa Mäki-Petäjä, Carmel M. McEniery, Yi Ping Bao, Sharon Wallace, Joseph Cheriyan, Sue Monteith, Morris J. Brown, Ian B. Wilkinson
Publicado 2005Artigo -
19
Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2) por Katrijn Bogman, Dietmar Schwab, Marie‐Laure Delporte, Giuseppe Palermo, Kurt E. Amrein, Susanne Mohr, Maria Cristina De Vera Mudry, Morris J. Brown, Philippe Ferber
Publicado 2016Artigo -
20
Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Ev... por David Rorie, Amy Rogers, Isla S. Mackenzie, Ian Ford, David J. Webb, Bryan Willams, Morris J. Brown, Neil R Poulter, Evelyn Findlay, Wendy Saywood, Thomas M. MacDonald
Publicado 2016Artigo
Herramientas de búsqueda:
Materias Relacionadas
Medicine
Internal medicine
Endocrinology
Biology
Blood pressure
Gene
Genetics
Aldosterone
Genotype
Chemistry
Genome-wide association study
Single-nucleotide polymorphism
Pathology
Alternative medicine
Cardiology
Pharmacology
Placebo
Engineering
Mechanical engineering
Primary aldosteronism
Stroke (engine)
Bioinformatics
Diuretic
Receptor
Renin–angiotensin system
Biochemistry
Computational biology
Confidence interval
Diabetes mellitus
Environmental health